Nifty
Sensex
:
:
10791.55
35929.64
53.95 (0.50%)
150.57 (0.42%)

Pharmaceuticals & Drugs

Rating :
46/99

BSE: 524764 | NSE: Not Listed

19.40
1.55 (8.68%)
13-Dec-2018 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  18.30
  •  19.50
  •  17.50
  •  17.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  34266
  •  6.65
  •  51.05
  •  14.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 60.85
  • 14.77
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 132.18
  • N/A
  • 0.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 40.07%
  • 6.15%
  • 46.59%
  • FII
  • DII
  • Others
  • 0%
  • 0.02%
  • 7.17%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.83
  • 12.09
  • 12.05

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.20
  • -1.96
  • -5.33

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.22
  • -46.28
  • -73.96

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.02
  • 2.05
  • 20.89

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.97
  • 2.60
  • 2.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 38.52
  • 55.44
  • 74.44

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 15
Mar 14
Mar 12
Net Sales
-
65.04
61.69
44.71
Net Sales Growth
-
5.43%
37.98%
 
Cost Of Goods Sold
-
47.25
41.48
30.47
Gross Profit
-
17.79
20.21
14.24
GP Margin
-
27.35%
32.76%
31.85%
Total Expenditure
-
61.85
51.50
38.46
Power & Fuel Cost
-
2.83
1.50
1.76
% Of Sales
-
4.35%
2.43%
3.94%
Employee Cost
-
2.96
1.94
1.75
% Of Sales
-
4.55%
3.14%
3.91%
Manufacturing Exp.
-
6.28
4.51
2.70
% Of Sales
-
9.66%
7.31%
6.04%
General & Admin Exp.
-
0.57
0.70
0.43
% Of Sales
-
0.88%
1.13%
0.96%
Selling & Distn. Exp.
-
0.67
0.62
0.55
% Of Sales
-
1.03%
1.01%
1.23%
Miscellaneous Exp.
-
1.31
0.75
0.80
% Of Sales
-
2.01%
1.22%
1.79%
EBITDA
-
3.19
10.19
6.25
EBITDA Margin
-
4.90%
16.52%
13.98%
Other Income
-
0.20
0.10
0.17
Interest
-
4.52
3.57
1.55
Depreciation
-
1.40
1.61
0.63
PBT
-
-2.51
5.11
4.24
Tax
-
-1.59
1.98
1.30
Tax Rate
-
28.14%
38.75%
30.66%
PAT
-
-4.06
3.13
2.94
PAT before Minority Interest
-
-4.06
3.13
2.94
Minority Interest
-
0.00
0.00
0.00
PAT Margin
-
-6.24%
5.07%
6.58%
PAT Growth
-
-
6.46%
 
Unadjusted EPS
-
-6.21
5.33
5.81

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Mar 12
Shareholder's Funds
20.25
12.78
Share Capital
5.89
5.20
Total Reserves
14.35
7.59
Non-Current Liabilities
17.81
8.33
Secured Loans
12.04
4.79
Unsecured Loans
2.41
1.89
Long Term Provisions
0.28
0.17
Current Liabilities
37.64
23.37
Trade Payables
19.07
12.51
Other Current Liabilities
2.92
2.49
Short Term Borrowings
14.33
6.29
Short Term Provisions
1.33
2.08
Total Liabilities
75.70
44.48
Net Block
35.67
19.35
Gross Block
41.58
22.39
Accumulated Depreciation
5.91
2.90
Non Current Assets
36.71
21.01
Capital Work in Progress
1.04
0.05
Non Current Investment
0.00
1.62
Long Term Loans & Adv.
0.00
0.00
Other Non Current Assets
0.00
0.00
Current Assets
38.90
23.47
Current Investments
0.00
0.00
Inventories
19.26
6.82
Sundry Debtors
14.77
12.06
Cash & Bank
1.48
1.37
Other Current Assets
3.39
1.81
Short Term Loans & Adv.
1.13
1.41
Net Current Assets
1.26
0.10
Total Assets
75.70
44.48

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 14
Cash From Operating Activity
0.00
PBT
0.00
Adjustment
0.00
Changes in Working Capital
0.00
Cash after chg. in Working capital
0.00
Interest Paid
0.00
Tax Paid
0.00
Other Direct Exp. Paid
0.00
Extra & Other Items
0.00
Cash From Investing Activity
0.00
Net Fixed Assets
Net Investments
Others
Cash from Financing Activity
0.00
Net Cash Inflow / Outflow
0.00
Opening Cash & Equivalents
0.00
Closing Cash & Equivalent
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 15
Mar 14
Mar 12
Book Value (Rs.)
16.33
15.59
11.18
ROA
-4.29%
5.23%
6.62%
ROE
-13.46%
18.98%
23.03%
ROCE
-1.65%
21.85%
20.93%
Fixed Asset Turnover
2.16
2.14
2.15
Receivable days
71.12
71.58
91.49
Inventory Days
92.56
69.57
51.74
Payable days
115.35
110.64
116.65
Cash Conversion Cycle
48.33
30.51
26.57
Total Debt/Equity
1.00
1.56
1.17
Interest Cover
-0.25
2.43
3.73

News Update:


  • Nutraplus India - Quarterly Results
    14th Nov 2018, 16:44 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.